Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease.
about
Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Back to the future: new target ...... ology and Parkinson's disease.
@en
Back to the future: new target ...... ology and Parkinson's disease.
@nl
type
label
Back to the future: new target ...... ology and Parkinson's disease.
@en
Back to the future: new target ...... ology and Parkinson's disease.
@nl
prefLabel
Back to the future: new target ...... ology and Parkinson's disease.
@en
Back to the future: new target ...... ology and Parkinson's disease.
@nl
P2860
P356
P1433
P1476
Back to the future: new target ...... ology and Parkinson's disease.
@en
P2860
P304
P356
10.1042/BCJ20170870
P4011
73f537c4b6a6f927e4cb4950be31abd73d97cda7
P407
P50
P577
2018-01-05T00:00:00Z